RAPT - CIK 0001673772
The table below shows RAPT Therapeutics, Inc.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $37.93M | $41.89M | $60.26M | $37.90M | $37.08M | $45.32M |
| Short-term investments | $119.41M | $127.06M | $119.02M | $60.01M | $77.76M | $96.26M |
| Receivables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Total current assets |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $161.04M |
| $172.86M |
| $183.20M |
| $102.60M |
| $120.50M |
| $148.36M |
| Property, plant & equipment | $765.00K | $970.00K | $1.16M | $1.65M | $1.93M | $2.24M |
| Goodwill | - | - | - | - | - | - |
| Total assets | $165.74M | $178.41M | $187.57M | $108.47M | $127.18M | $155.82M |
| Accounts payable | $2.10M | $4.19M | $1.29M | $1.38M | $2.72M | $6.77M |
| Total current liabilities | $13.38M | $13.04M | $8.68M | $10.36M | $14.80M | $21.17M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $13.76M | $14.00M | $10.20M | $12.96M | $17.96M | $24.98M |
| Retained earnings | -$666.93M | -$649.36M | -$631.71M | -$561.30M | -$542.87M | -$515.20M |
| Total equity | $151.98M | $164.41M | $177.37M | $95.51M | $109.22M | $130.84M |